Tag :

EastGate Biotech Corp. Press Releases

EastGate Biotech Expands Indications of Liquid Insulin Mouth Rinse Solution to Alzheimer's Disease with Joint Venture Partner Genome Pharmaceuticals

EastGate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of type 2 diabetes, announced the expansion of the Pakistani  joint venture agreement to include the treatment…

EastGate Biotech Unveils Manufacturing Plans in an MOU with Mystic Pharmaceuticals Limited for Its Liquid Insulin Mouth Rinse Solution

​​EastGate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes, announced it entered into a Memorandum of Understanding (MOU) with Mystic Pharmaceuticals Limited…

EastGate Biotech Announces Definitive Agreement with Genluiching Mining Corporation

  EastGate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of type 2 diabetes, announced a definitive agreement with Genluiching Mining Corporation.  As per the previously…

EastGate Biotech Announces that It Has Reached a Definitive Settlement Agreement with Northbridge Financial Inc.

EastGate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of type 2 diabetes, announced today that it has reached a definitive settlement agreement with Northbridge Financial. …

EastGate Biotech Enters Into a MOU with Genluiching Mining Corp. and AAH & International Associates Inc. of the Philippines

EastGate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of type 2 diabetes, is pleased to announce that has signed a Memorandum of Understanding (MOU) with…

EastGate Biotech Announces Licensing/Distribution MOU With BuPharco for the Insulin Mouth Rinse in the Philippines for Type 2 Diabetes Patients

  EastGate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of type 2 diabetes.   We are thrilled to announce today that EastGate has signed a Memorandum…

Eastgate Biotech Provides Corporate Update

EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company that focuses on innovative pharmaceutical developments and produces and distributes innovative and healthy nutraceuticals based on natural therapies has announced today its corporate update. EastGate Biotech is pleased to provide…

EastGate Biotech Announces Annual Report Form 10-K Filing

EastGate Biotech (OTC PINK: ETBI) a market leading pharmaceutical technology company, today announced that it filed an Annual Report on Form 10-K under the U.S. Securities Exchange Act of 1934 for EastGate Biotech for the period through December 31, 2017…

EastGate Biotech Announces Opening of Representative Office in the Philippines

  EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company that focuses on innovative pharmaceutical developments and produces and distributes innovative and healthy nutraceuticals based on natural therapies, has announced today that it has opened a representative office in Manila,…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login